{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:50:40Z","timestamp":1787871040416,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.diagmicrobio.2014.02.003","type":"journal-article","created":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T11:47:03Z","timestamp":1393069623000},"page":"280-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medell\u00edn, Colombia 2010\u20132011"],"prefix":"10.1016","volume":"79","author":[{"given":"Natalia Andrea","family":"Maldonado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Elena","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"De Bedout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Arbel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Roncancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela Mar\u00eda","family":"Tabares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Gonzalo","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National surveillance of fungemia in Denmark (2004 to 2009)","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2014.02.003_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-6-21","article-title":"Epidemiological trends in nosocomial candidemia in intensive care","volume":"6","author":"Bassetti","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.02.003_bb0015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1358\/dot.2003.39.10.799473","article-title":"Clinical impact of drug-drug interactions with systemic azole antifungals","volume":"39","author":"Bates","year":"2003","journal-title":"Drugs Today"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0020","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.05947-11","article-title":"Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection","volume":"56","author":"Ben-Ami","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.02.003_bb0060","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Third Informational Supplement. CLSI Document M27-S","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2014.02.003_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2110-5820-1-37","article-title":"Diagnosis of invasive candidiasis in the ICU","volume":"1","author":"Eggimann","year":"2011","journal-title":"Ann Intensive Care"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0035","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ijid.2010.04.006","article-title":"Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review","volume":"14","author":"Falagas","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0045","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.00479-10","article-title":"Risk factors for fluconazole-resistant candidemia","volume":"54","author":"Garnacho-Montero","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0050","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0055","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0065","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archinte.169.4.379","article-title":"Risk factors for fluconazole-resistant Candida glabrata bloodstream infections","volume":"169","author":"Lee","year":"2009","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0075","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/AAC.49.11.4555-4560.2005","article-title":"Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case\u2013control study","volume":"49","author":"Lin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0080","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0085","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s100960000323","article-title":"Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients","volume":"19","author":"Masi\u00e1 Canuto","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0090","doi-asserted-by":"crossref","first-page":"e2011007","DOI":"10.4084\/mjhid.2011.007","article-title":"Invasive candidiasis in non-hematological patients","volume":"3","author":"Mikulska","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/655683","article-title":"Epidemiology of opportunistic fungal infections in Latin America","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1130-1406(06)70009-2","article-title":"Factores de riesgo de la candidiasis invasora: estratificaci\u00f3n","volume":"23","author":"Del Palacio","year":"2006","journal-title":"Rev Iberoam Micol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0105","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/376906","article-title":"A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0120","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/JCM.00946-09","article-title":"Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"CLSI Subcommittee for Antifungal Susceptibility Testing. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for Fluconazol and Candida time for harmonization of CLSI and EUCAST broth microdilution","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Updat"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0130","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","article-title":"Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria","volume":"70","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/JCM.01398-10","article-title":"Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0150","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1097\/CCM.0b013e3181760f42","article-title":"Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp","volume":"36","author":"Playford","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0155","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1128\/JCM.02591-05","article-title":"Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp","volume":"44","author":"Sims","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0160","first-page":"135","article-title":"Evaluaci\u00f3n mediante tres t\u00e9cnicas de susceptibilidad a fluconazol en especies de Candida aisladas en pacientes con infecciones invasoras","volume":"26","author":"Torres","year":"2009","journal-title":"Bogot\u00e1 \u2013 Colombia. Rev Chil Infect"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0170","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/jac\/dkn381","article-title":"Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome","volume":"62","author":"Tumbarello","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0175","first-page":"185","article-title":"Prevalencia de patrones de sensibilidad al fluconazol de las especies de Candida aisladas de pacientes de unidades de cuidados intensivos de Bucaramanga-Colombia","volume":"8","author":"Villar","year":"2004","journal-title":"Infectio"},{"issue":"21","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0180","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0185","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1001\/archinte.1988.00380120094019","article-title":"Hospital acquired candidemia. The attributable mortality and excess length of stay","volume":"148","author":"Wey","year":"1988","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0190","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/591033","article-title":"Secular trends in candidemia-related hospitalization in the United States, 2000\u20132005","volume":"29","author":"Zilberberg","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.02.003_bb0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.riam.2010.04.001","article-title":"Sensibilidad a fluconazol y voriconazol de especies de Candida aisladas de pacientes provenientes de unidades de cuidados intensivos en Medell\u00edn, Colombia (2001\u20132007)","volume":"27","author":"Zuluaga","year":"2010","journal-title":"Rev Iberoam Micol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T12:24:47Z","timestamp":1538828687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889314000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0732889314000662"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.02.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of clinical and demographic factors in invasive candidiasis caused by fluconazole-resistant Candida species: a study in 15 hospitals, Medell\u00edn, Colombia 2010\u20132011","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}